BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 11997397)

  • 1. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
    Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
    J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
    Cheng KF; Al-Abed Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis.
    Al-Abed Y; Dabideen D; Aljabari B; Valster A; Messmer D; Ochani M; Tanovic M; Ochani K; Bacher M; Nicoletti F; Metz C; Pavlov VA; Miller EJ; Tracey KJ
    J Biol Chem; 2005 Nov; 280(44):36541-4. PubMed ID: 16115897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
    Garai J; Lóránd T
    Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
    Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
    Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fluorinated analog of ISO-1 blocks the recognition and biological function of MIF and is orally efficacious in a murine model of colitis.
    Dagia NM; Kamath DV; Bhatt P; Gupte RD; Dadarkar SS; Fonseca L; Agarwal G; Chetrapal-Kunwar A; Balachandran S; Srinivasan S; Bose J; Pari K; B-Rao C; Parkale SS; Gadekar PK; Rodge AH; Mandrekar N; Vishwakarma RA; Sharma S
    Eur J Pharmacol; 2009 Apr; 607(1-3):201-12. PubMed ID: 19239912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
    Orita M; Yamamoto S; Katayama N; Fujita S
    Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.
    Orita M; Yamamoto S; Katayama N; Aoki M; Takayama K; Yamagiwa Y; Seki N; Suzuki H; Kurihara H; Sakashita H; Takeuchi M; Fujita S; Yamada T; Tanaka A
    J Med Chem; 2001 Feb; 44(4):540-7. PubMed ID: 11170644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
    Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
    Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
    Trivedi-Parmar V; Robertson MJ; Cisneros JA; Krimmer SG; Jorgensen WL
    ChemMedChem; 2018 Jun; 13(11):1092-1097. PubMed ID: 29575754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.
    Dios A; Mitchell RA; Aljabari B; Lubetsky J; O'Connor K; Liao H; Senter PD; Manogue KR; Lolis E; Metz C; Bucala R; Callaway DJ; Al-Abed Y
    J Med Chem; 2002 Jun; 45(12):2410-6. PubMed ID: 12036350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 A resolution.
    Sugimoto H; Taniguchi M; Nakagawa A; Tanaka I; Suzuki M; Nishihira J
    Biochemistry; 1999 Mar; 38(11):3268-79. PubMed ID: 10079069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human single-chain variable fragment antibody inhibits macrophage migration inhibitory factor tautomerase activity.
    Tarasuk M; Poungpair O; Ungsupravate D; Bangphoomi K; Chaicumpa W; Yenchitsomanus PT
    Int J Mol Med; 2014 Mar; 33(3):515-22. PubMed ID: 24424397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis.
    Tan TH; Edgerton SA; Kumari R; McAlister MS; Roe SM; Nagl S; Pearl LH; Selkirk ME; Bianco AE; Totty NF; Engwerda C; Gray CA; Meyer DJ
    Biochem J; 2001 Jul; 357(Pt 2):373-83. PubMed ID: 11439086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.
    Xiong C; Huang B; Cun Y; Aghdasi BG; Zhou Y
    Clin Orthop Relat Res; 2014 Jun; 472(6):1943-54. PubMed ID: 24569872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor.
    Crichlow GV; Cheng KF; Dabideen D; Ochani M; Aljabari B; Pavlov VA; Miller EJ; Lolis E; Al-Abed Y
    J Biol Chem; 2007 Aug; 282(32):23089-95. PubMed ID: 17526494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.
    Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R
    Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
    Vera PL; Iczkowski KA; Howard DJ; Jiang L; Meyer-Siegler KL
    Neurourol Urodyn; 2010 Nov; 29(8):1451-7. PubMed ID: 20127836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of chromenes as inhibitors of macrophage migration inhibitory factor.
    Kok T; Wapenaar H; Wang K; Neochoritis CG; Zarganes-Tzitzikas T; Proietti G; Eleftheriadis N; Kurpiewska K; Kalinowska-Tłuścik J; Cool RH; Poelarends GJ; Dömling A; Dekker FJ
    Bioorg Med Chem; 2018 Mar; 26(5):999-1005. PubMed ID: 29428527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness.
    Jovanović Krivokuća M; Stefanoska I; Abu Rabi T; Al-Abed Y; Stošić-Grujičić S; Vićovac Lj
    Placenta; 2015 Feb; 36(2):150-9. PubMed ID: 25530499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.